release antibody test

The release antibody test is mainly for the detection of the cause of neonatal jaundice of "O" type mother, "A" or "B" type, and whether the infant has ABO blood group system immune hemolytic disease release antibody test inspection process: by heating The sensitized erythrocyte-conjugated blood group antibody from the mother is released into the release solution, and the release solution is mixed with the same type of adult red blood cells to cause coagulation. Basic Information Specialist classification: maternity check check classification: blood test Applicable gender: whether women are fasting: fasting Analysis results: Below normal: Normal value: no Above normal: negative: Generally should be normal. Positive: It is possible to determine the presence of antibodies from the mother in the neonate and cause hemolytic disease in the newborn. Tips: Relax your body and actively cooperate with your doctor. Normal value The release antibody test was negative. Clinical significance Abnormal result Positive test can determine the presence of antibodies from the mother in the newborn and cause hemolytic disease in the newborn. People who need to be examined: pregnant women with different blood types or different maternal and child blood types. Positive results may be diseases: maternal and child blood group incompatibility hemolytic disease, neonatal hemolytic disease precautions Before the examination: fasting, taking blood in the morning is better. When checking: Relax your body and actively cooperate with your doctor. Inspection process The blood group antibody derived from the mother, which binds the sensitized red blood cells by the child, is released into the release liquid, and the release liquid is mixed with the same type of adult red blood cells to cause coagulation. Not suitable for the crowd 1. Patients who have taken contraceptives, thyroid hormones, steroid hormones, etc., may affect the results of the examination and prohibit patients who have recently taken the drug history. 2, special diseases: patients with hematopoietic function to reduce disease, such as leukemia, various anemia, myelodysplastic syndrome, etc., unless the examination is essential, try to draw less blood. Adverse reactions and risks 1, subcutaneous hemorrhage: due to pressing time less than 5 minutes or blood draw technology is not enough, etc. can cause subcutaneous bleeding. 2, discomfort: the puncture site may appear pain, swelling, tenderness, subcutaneous ecchymosis visible to the naked eye. 3, dizzy or fainting: in the blood draw, due to emotional overstress, fear, reflex caused by vagus nerve excitement, blood pressure decreased, etc. caused by insufficient blood supply to the brain caused by fainting or dizziness. 4. Risk of infection: If you use an unclean needle, you may be at risk of infection.